SARS and Avian Flu Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SARS and Avian Flu

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (2722)	10/15/2005 1:51:44 PM
From: Elroy Jetson	Read Replies (1) of 4232

Purely an economic problem? Well in a way. After many, many years of trials of IGG therapy for HIV, Hemacare gave up because no one was interested in paying money for a therapy which provided significant side-effects without benefit. People are very small minded that way. I have no idea where you developed the idea that TNF is the super-antigen the immune system responds to in what some call a "cytokine storm". TNF is a cytokine created by the immune system in response to a super-antigen, not an antigen. The response is driven by IL-1 and TNF, but TNF is not the antigen which triggers the reaction. .

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next